How to Calculate Your BMI (and Why It's Not the Whole Story)

Every GLP-1 eligibility conversation starts the same way: step on a scale, check your height, calculate a number. That number — your body mass index — determines whether most insurance companies and prescribing guidelines consider you a candidate for medications like semaglutide or tirzepatide.

But BMI is a screening tool, not a diagnosis. Understanding what it measures, what it misses, and what your doctor should actually be evaluating gives you a significant advantage in your first appointment.

The Standard GLP-1 Eligibility Criteria

Most prescribing guidelines — and the FDA-approved labels for Wegovy and Zepbound — use these thresholds:

• BMI of 30 or higher (classified as obesity) — eligible regardless of other conditions
• BMI of 27 to 29.9 (classified as overweight) — eligible if you also have at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or cardiovascular disease

For the Medicare GLP-1 Bridge program launching July 2026, the thresholds are slightly different: a BMI of 35+ qualifies automatically, while BMI 30+ requires specific comorbidities like heart failure, uncontrolled hypertension, or CKD stage 3a+. Those with a BMI of 27+ need pre-diabetes, prior heart attack, prior stroke, or symptomatic peripheral artery disease.

How BMI Is Actually Calculated

BMI is a simple math formula: your weight in kilograms divided by your height in meters squared. In American units, it's your weight in pounds multiplied by 703, then divided by your height in inches squared.

For example, someone who is 5'8" (68 inches) and weighs 200 pounds has a BMI of approximately 30.4 — just over the obesity threshold.

Why BMI Doesn't Tell the Whole Story

BMI was invented in the 1830s by a Belgian mathematician who was studying population averages — not individual health. The formula doesn't distinguish between muscle and fat, doesn't account for where your body stores fat, and was originally calibrated on European male populations.

Here's what BMI misses:

• Body composition: A muscular person at 5'10" and 210 pounds has a BMI of 30.1 but may have 15% body fat. BMI would classify them as obese.
• Fat distribution: Visceral fat (around the organs) is far more dangerous than subcutaneous fat (under the skin). Two people with identical BMIs can have radically different metabolic risk profiles depending on where they carry weight.
• Ethnic variation: Research has shown that Asian populations face elevated metabolic risk at lower BMIs (around 23–25), while some Pacific Islander populations maintain metabolic health at higher BMIs.
• Age and sex: Older adults tend to lose muscle mass and gain fat, which BMI can't detect. Women naturally carry more body fat than men at equivalent BMIs.

What Your Doctor Should Actually Evaluate

A thorough GLP-1 eligibility assessment goes beyond the scale. Here's what a good provider will look at:

Waist Circumference

Waist circumference is one of the strongest predictors of cardiometabolic risk. Guidelines from the NIH identify increased risk at a waist circumference above 35 inches for women and 40 inches for men. Some providers use the waist-to-hip ratio for a more nuanced picture.

Metabolic Markers

Blood work reveals what the scale can't. Your doctor should check fasting glucose and HbA1c (diabetes risk), a lipid panel (cholesterol and triglycerides), blood pressure, and liver enzymes. Elevated levels in any of these — even with a BMI under 30 — may strengthen a case for GLP-1 therapy.

Weight History

Your doctor should ask about your weight trajectory, not just your current weight. Patterns matter: have you gained steadily over years? Have you experienced weight regain after successful diets? A history of weight cycling (yo-yo dieting) is itself a clinical consideration.

Functional Impact

Joint pain, mobility limitations, sleep apnea, shortness of breath during normal activity — these functional impacts of excess weight are clinically relevant even if your BMI is in a borderline range.

When BMI Says No but Clinical Evidence Says Maybe

If your BMI is between 25 and 27 — below the standard threshold — you're not automatically out of the running. Many telehealth providers and some in-person physicians will consider prescribing GLP-1 medications when other risk factors are present, particularly for compounded formulations that aren't bound by the same label restrictions as brand-name drugs.

Key situations where providers may consider treatment below BMI 27:

• Pre-diabetic blood sugar levels with a strong family history of type 2 diabetes
• Central obesity (high waist circumference) despite a lower overall BMI
• Metabolic syndrome — meeting three or more criteria for insulin resistance, elevated triglycerides, low HDL, elevated blood pressure, and high waist circumference

This is a conversation to have with your provider. Come prepared with your lab work and medical history, and ask specifically: "Based on my full metabolic picture, do you think GLP-1 therapy is appropriate?"

What to Do Before Your Appointment

Preparation makes a difference. Before your GLP-1 consultation:

1. Know your numbers: Calculate your BMI, measure your waist circumference, and pull any recent blood work results.
2. Document your weight history: Bring a timeline of your weight over the past 5–10 years, including any diets, programs, or medications you've tried.
3. List your conditions: Every weight-related condition you have strengthens your eligibility case — even conditions you might not think of, like GERD, PCOS, or depression.
4. Check your insurance: Call your insurance and ask whether GLP-1 medications are covered under your plan and what prior authorization requirements exist.

The Bottom Line

BMI is the gateway to the GLP-1 conversation, but it shouldn't be the entire conversation. A responsible provider will look at your complete metabolic profile, your weight history, your functional limitations, and your overall health goals before making a prescribing decision.

If you've been told your BMI is "too low" for treatment but you're experiencing genuine health impacts from your weight, seek a second opinion — ideally from a provider who specializes in obesity medicine or metabolic health. The science of eligibility is more nuanced than a single number.